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Abstract
In the vertebrates, the BMP/Smad1 and TGF-b/Smad2 signaling pathways execute antagonistic functions in different
contexts of development. The differentiation of specific structures results from the balance between these two pathways.
For example, the gastrula organizer/node of the vertebrates requires a region of low Smad1 and high Smad2 signaling. In
Drosophila, Mad regulates tissue determination and growth in the wing, but the function of dSmad2 in wing patterning is
largely unknown. In this study, we used an RNAi loss-of-function approach to investigate dSmad2 signaling during wing
development. RNAi-mediated knockdown of dSmad2 caused formation of extra vein tissue, with phenotypes similar to
those seen in Dpp/Mad gain-of-function. Clonal analyses revealed that the normal function of dSmad2 is to inhibit the
response of wing intervein cells to the extracellular Dpp morphogen gradient that specifies vein formation, as measured by
expression of the activated phospho-Mad protein. The effect of dSmad2 depletion in promoting vein differentiation was
dependent on Medea, the co-factor shared by Mad and dSmad2. Furthermore, double RNAi experiments showed that Mad
is epistatic to dSmad2. In other words, depletion of Smad2 had no effect in Mad-deficient wings. Our results demonstrate a
novel role for dSmad2 in opposing Mad-mediated vein formation in the wing. We propose that the main function of
dActivin/dSmad2 in Drosophila wing development is to antagonize Dpp/Mad signaling. Possible molecular mechanisms for
the opposition between dSmad2 and Mad signaling are discussed.
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Introduction
Signaling by the transforming growth factor-b (TGF-b)
superfamily of ligands is important for proliferation, differentia-
tion, and cell fate determination during embryonic development
and tissue homeostasis in the adult. This group of ligands can be
divided into two broad signaling families, the Bone Morphogenetic
Protein (BMP) and the TGF-b/Activin pathways. Their signal
transduction pathways are highly conserved in animal species, and
homologues of most components have been described from
nematodes to humans. A group of transcription factors known as
R-Smads (Receptor-Smads) transduce the intracellular signal of
each pathway.
In the vertebrates, the BMP pathway signals through Smad1/5/
8, while Smad2/3 relay signals of the TGF-b/Activin pathway [1].
BMP ligands bind to and activate BMP receptors (BMPR, type I
and II), causing Smad1/5/8 phosphorylation at its two C-terminal
serines (SVS). Phosphorylated Smad1
cter then binds to Smad4 (co-
Smad) and this complex translocates and accumulates in the
nucleus, activating BMP-responsive genes. The pSmad1
cter signal
is fine-tuned by a number of inhibitory phosphorylations at
Mitogen Activated Protein Kinase (MAPK) and Glycogen
Synthase Kinase 3 (GSK3) sites in the linker/middle domain of
the protein. Linker phosphorylation results in the rapid termina-
tion of the BMP/Smad1 signal by a process of polyubiquitination
followed by proteasomal degradation in the centrosomal region of
the cell [2–8]. The reverse effect is mediated by PP2A (Protein
Phosphatase 2A), which has been shown to be the first stimulatory
phosphatase of the BMP pathway. PP2A preferentially dephos-
phorylates the Smad1 linker region, leading to prolonged BMP
signaling [9]. In Drosophila, BMP signaling is mediated by the
secreted ligands Decapentaplegic (Dpp), Screw (Scw) and Glass
bottom boat (Gbb), the type I receptors Thickveins (Tkv) and
Saxophone (Sax), the type II receptors Punt and Wishful thinking
(Wit) the Smad1/5/8 homolog Mothers against Dpp (Mad), and
the Smad4 homolog Medea [10–12].
TGF-b/Activin signals are transduced in a similar fashion as the
BMP branch, via binding to type I and II receptors, C-terminal
phosphorylation of Smad2/3 (at SMS or SVS sites), followed by
complex formation with Smad4 and transcriptional activation of
target genes in the nucleus [1]. Several studies have addressed the
function of the Activin pathway in Drosophila [13–18]. The secreted
ligands Drosophila Activin (dAct) and Dawdle (Daw) have been
shown to signal through the type I receptor Baboon (Babo)
[13,18]. dSmad2 was first described by Henderson and Andrew
and named Smox, for Smad on chromosome X [19]. Sequence
alignments revealed high similarity of dSmad2 to vertebrate
Smad2 and Smad3. Functionally, it appears that dSmad2 is more
similar to Smad3, due to the lack of a 30 amino acids insertion in
the MH1 domain present in some isoforms of vertebrate Smad2
that prevent binding to DNA [11,13,14]. It should be noted that
the dAct/dSmad2 signal transduction pathway shares three
components with the Dpp/Mad branch: the type II receptors
Punt and Wit, and the co-Smad Medea [14,17].
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and Smad2 signals have been shown to function antagonistically.
For example, in the Xenopus gastrula two morphogens have been
identified: BMP4 and TGF-b/Nodal. These growth factors
establish a bidirectional antagonistic embryonic field, which is
interpreted by intracellular Smad1 and Smad2 signals [20]. The
antagonism takes place at different levels. Extracellularly, Nodal/
Smad2 induce the transcription of anti-BMPs, such as Chordin
and Noggin, which inhibit BMP4 by binding to it [21].
Intracellularly, Smad1 inhibits activation of Smad2 transcriptional
targets, and Smad2 activation inhibits Smad1 target genes [20,22–
25]. In this way, mutually exclusive regions of high Smad1 or
Smad2 signaling are established on opposite sides of the early
embryo. At the level of tissue-specific Smad-induced transcription
factors, this antagonism is illustrated by the opposing functions of
the homeobox genes Vent1/2, induced by Smad1 on the ventral
side, and Goosecoid, a target gene of Smad2 on the dorsal side,
during mesoderm patterning and self-regulation of the early frog
embryo [26]. Another example of the importance of the
antagonism between Smad1 and Smad2 was recently reported
by Yamamoto and co-workers [27]. The authors demonstrated
that development of the distal visceral endoderm, which
determines the orientation of the anterior-posterior axis in the
mouse, requires the formation of a region where Smad2 signaling
is high and Smad1 is absent.
The Drosophila wing provides an excellent model system to study
intercellular signal regulation [28]. Dpp/Mad promotes vein
differentiation during larval and pupal stages of development
[29,30], as well as wing growth [31–34]. Loss-of-function
mutations at the ligand, receptor or transcription factor level of
the Dpp signaling pathway have been shown to be required for
vein formation and wing growth. Conversely, overexpression of
Dpp, activated Tkv receptor or degradation-resistant Mad caused
increased vein formation [6,12,35].
The role of dSmad2 in wing development is much less
understood in Drosophila. It has been reported that dSmad2 may
play a modest role in the proliferation of wing cells, without
affecting patterning and gene expression [13,17]. These studies
were performed by overexpression of activated dSmad2 (phospho-
mimicking mutations of the C-terminal serines, dSmad2-DMD)
[17], or, in a more indirect approach, using a constitutively-active
and mutant version of Babo receptor [13]. As for dSmad2
mutations, there is only one dSmad2/Smox allele available, a
missense mutation that has not been studied in the wing [15].
The present study was initiated to determine the role of dSmad2
during wing development through a loss-of-function approach
Figure 1. dSmad2 RNAi induces vein tissue differentiation. (A) Control wing showing the location of the longitudinal veins 2–5 (L2–L5);
anterior crossvein (ACV); posterior crossvein (PCV). (B) dSmad2 RNAi driven by MS1096-Gal4 leads ectopic vein tissue formation in the vicinity of L5
(arrows). (C) A similar phenotype is observed in flies overexpressing Mad. (E) Overexpression of the dSmad2 homologue human Smad3 results in a
partial loss of L4 and L5; an identical phenotype is seen in some Dpp partial loss-of-function mutants [48]. (F) human Smad3 rescues the dSmad2 RNAi
phenotype (arrows), demonstrating dSmad2 RNAi specifically depletes dSmad2.
doi:10.1371/journal.pone.0010383.g001
dSmad2 Opposes Mad Signaling
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available [36,37]. To our surprise, we found that dSmad2 serves
mainly to oppose signaling through Mad in the developing wing.
Depletion of dSmad2 in wing imaginal discs caused increased vein
tissue development. This was the opposite of Mad knockdown,
which inhibited vein formation. Analysis of dSmad2 RNAi clones
revealed an increase in nuclear phospho-Mad levels in pupal wings
during vein formation. In double RNAi depletion experiments,
Mad was epistatic to dSmad2, showing that the dSmad2 loss-of-
function phenotypes arose through increased Mad activity. We
discuss possible molecular mechanisms that might explain the
inhibitory effect of dSmad2 on Mad.
Results
RNAi-mediated knockdown of dSmad2 increases vein
formation in Drosophila wings
We investigated the function of dSmad2 in Drosophila wing
development using UAS/RNAi transgenic flies from the Vienna
DrosophilaRNAiCenter.DrivingUAS-dSmad2RNAiubiquitously
in the wing blade using the MS1096-Gal4 driver resulted in
increased vein tissue formation along longitudinal vein 5 (L5), when
compared to an adult wild-type wing (compare Figure 1A to 1B).
This phenotype was similar to the overexpression of UAS-Mad wild-
type (Figure 1C). The dSmad2 RNAi used in most of this study
targeted a 400 bp nucleotide fragment corresponding to the linker
domain and part of the MH2 region of dSmad2 (GD14609, Figure
S1A in Supporting Information). A second independent RNAi line
targetingtheMH1domainofdSmad2(KK105687,FigureS1A)was
drivenunder the sameconditions,and alsocaused ectopic veintissue
alongL5(Figure S1A).Theincreaseinveintissuecaused bydSmad2
RNAi was rescued to wild-type levels by co-expression of a human
SMAD3 transgene (compareFigure 1B to1F). Taken together, these
findings indicate that the function of endogenous dSmad2 is to
negatively regulate vein formation in the Drosophila wing.
Another indication that dSmad2 knockdown causes elevated
Mad signaling was the appearance of ectopic sensory bristles in
wing blade intervein tissues (Figure S2). Ectopic bristles are also
observed when hyperactive Mad mutants are overexpressed in the
fly wing [6]. We next investigated further the hypothesis that loss
of dSmad2 phenocopies an increase in Dpp/Mad signaling.
dSmad2 knockdown phenocopies Dpp overexpression in
the wing disc
Analysis of third instar wing imaginal discs overexpressing UAS-
Dpp (driven by Scalloped-Gal4), dSmad2 RNAi or Mad RNAi
revealed further phenotypic similarities between dSmad2 loss-of-
function and Mad gain-of-function. Overexpression of Dpp (which
activates Mad) or depletion of dSmad2 resulted in overgrowth of
wing imaginal discs when compared to wild-type discs (Figure 2A–
2C) [12]. Depletion of the Mad transcription factor using RNAi
[6] caused inhibition of wing imaginal disc growth (Figure 2D).
Overgrowth of wing discs by dSmad2 RNAi was prominent when
driven by scalloped-Gal4, but weaker when driven by MS1096-
Gal4; this may be explained by spatiotemporal differences in
driver expression. The results indicate that while Dpp/Mad
signaling promotes wing imaginal disc growth, endogenous
dSmad2 signaling has the opposite effect.
dSmad2 RNAi causes transformation of intervein into
vein tissue
Increased size of the third instar wing imaginal disc does not
necessarily generate enlarged adult wings. Mature vein cells are
smaller and more densely packed than intervein cells, in addition
to secreting more pigmented cuticle [29,38]. In a situation in
which more vein cells relative to intervein cells were differentiated,
without increasing overall cell proliferation, the final size of the
adult wing would be decreased. In addition, other processes such
as blisters due to imperfect alignment of the two wing surfaces or
increased apoptosis could contribute to a decrease in wing size. In
case of dSmad2 knockdown (driven by MS1096-Gal4), we
observed a smaller adult wing size accompanied by moderately
increased vein formation at room temperature (Figure S1E). These
effects became more severe when the flies were grown at a higher
temperature (29uC) (Figure 3B). dSmad2-depleted wings were
much smaller than control wings at this temperature, and
displayed significantly wider L3 and L5 veins (compare
Figure 3A to 3B). The smaller size and higher cell density of
vein cells (each wing cell is marked by a single trichome) compared
to neighboring intervein cells [29] is readily seen at higher
magnifications (insets in Figure 3A’–3C’’).
We compared the dSmad2 RNAi phenotype to gain-of-
function of Dpp in the adult wing. Despite the massive
overgrowth of the wing imaginal disc by overexpressing UAS-
Dpp (Figure 2B), at 20uC( f l i e sd on o te c l o s ea th i g h e r
temperatures) the resulting adult wings were found to be
significantly smaller than wild-type (Figure 3C). This size
difference is explained by the transformation of the larger
intervein cells into much smaller vein cells and higher cell density
(Figure 3C’ and 3C’’). The similarity of the phenotypes of
dSmad2 loss-of-function and Dpp/Mad gain-of-function in
imaginal discs (Figure 2) and in adult wings (Figure 3) suggested
Figure 2. Knockdown of dSmad2 resembles Dpp overexpres-
sion in the wing disc. (A) Control imaginal wing disc at third instar
stage, expressing Scalloped (Sd)-Gal4 throughout larval development of
the wing. (B) Overexpression of Dpp causes overgrowth of the wing
blade region of the disc. (C) dSmad2 RNAi phenocopies Dpp
overexpression, expanding the wing blade region. (D) Conversely,
downregulation of the Dpp pathway by Mad RNAi reduces the size of
the wing disc.
doi:10.1371/journal.pone.0010383.g002
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signaling pathways during Drosophila wing differentiation.
dSmad2 RNAi clones have increased Mad
cter
phosphorylation in vein tissue
We next investigated the mechanism of the proposed antago-
nism between dSmad2 and Mad by clonal analysis. A Drosophila
strain was constructed, in which dSmad2 RNAi flp-out clones
were marked by GFP in pupal wings and by yellow (y+) bristles in
adult wings [39]. Activation of Mad signaling was followed by
immunostaining with anti-phospho-Mad
cter antibody [40,41] on
pupal wings. C-terminal phosphorylation of Mad marking Dpp
pathway activity becomes visible around 22 hrs after puparium
formation (APF) in the crossveins, and soon after in the
longitudinal veins [41]. Figure 4A shows pMad
cter staining at
25 hrs APF in a wild-type pupal wing. Large clones of dSmad2
RNAi were obtained by a 1 hr heat-shock (37uC) 24 hrs after egg
laying (AEL) (Figure 4B’, clones labeled by GFP).
We observed ectopic vein formation in dSmad2 RNAi clones
predominantly in the posterior wing compartment (Figure 4B and
4B’). Importantly, regions of increased pMad
cter were observed
(arrowheads in Figure 4B and 4D). These were not uniform
throughout the clone, but instead appeared to correspond to
regions of ectopic vein formation, for they displayed nuclear
staining for pMad
cter at comparable levels to those of endogenous
pMad along L5 (arrows in Figure 4A–4D). The simplest
interpretation is that knockdown of dSmad2 causes increased
Mad signaling by making dSmad2-depleted cells more sensitive to
endogenous Dpp signals [38], although other mechanisms remain
possible. Although GFP-positive clones were distributed evenly
over the whole wing, we found ectopic vein formation primarily in
the posterior wing compartment near L5 and, in fewer cases, near
the anterior margin (Figure 4G and 4G’). These regional effects
may be due to the graded activity of endogenous pMad
cter, which
is normally lower far from the source of Dpp in the anterior-
posterior compartment boundary [34,42].
The increase in Mad signaling presumably explains the ectopic
vein phenotypes seen in dSmad2 RNAi clones in adult wings
(Figure 4E–4G). Although the clones are no longer visible with
GFP in the adult wing blade, the region of the clones could still be
identified in the anterior compartment by yellow bristles along the
wing margin. Figure 4E shows a clone in the anterior margin
marked by yellow bristles, with a nearby ectopic longitudinal vein
originating between the anterior margin and L2 (arrow). In
Figure 3. dSmad2 depletion leads to transformation of intervein into vein tissue. (A) Wild-type wing retains normal size and vein
patterning when grown at 29uC. A’ and A’’ insets show higher magnification of L3 and L5 regions to illustrate the size differences between vein and
intervein cells, each of which have a single hair (trichome) (B) Driving dSmad2 RNAi with MS1096-Gal4 at 29uC results in small wings due to increase in
vein tissue mostly near L3 (B’) and L5 (B’’). (C) Dpp-overexpressing flies display a similar wing phenotype to dSmad2 RNAi, although stronger. High
levels of Dpp/Mad lead to an overproduction of vein, resulting in wings of reduced size that are composed entirely of vein tissue (C’ and C’’). Flies
overexpressing Dpp in the wing only survive to adult stages when grown at low temperature (20uC).
doi:10.1371/journal.pone.0010383.g003
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the vicinity of the extra vein was also observed (Figure 4G,
arrowhead). These growths are indicative of ectopic wing
formation, which can be caused by increased Dpp signaling
[32,34]. Taken together, the studies in clones suggest that dSmad2
RNAi causes excessive vein formation by increasing pMad
cter
signaling.
dSmad2 requires Medea for its inhibitory effect on vein
formation
The loss-of-function studies described above indicate that
dSmad2 opposes Mad signaling during vein differentiation in the
fly wing. The mechanism for this opposition, however, remains
unclear. Both Mad and dSmad2 form a complex with the co-
Smad Medea before binding to DNA and activating target gene
expression [13,43,44]. To test whether Medea is required for the
inhibitory effect of dSmad2 on vein formation, we analyzed the
phenotype of depleting both genes in a combinational RNAi
knockdown approach. We used the UAS-Medea RNAi construct
KK106767 that targets nucleotides 1434 to 1883. Driving Medea
RNAi alone in the wing blade resulted in smaller wings with great
losses of vein tissue (Figure 5B). The residual vein tissue fails to
reach the distal margin, although the five normal veins can stil be
recognized. A second Medea RNAi construct had similar effects
(not shown). Depletion of dSmad2 results in increased venation
(Figure 1B). Simultaneous depletion of dSmad2 and Medea caused
vein tissue loss and a further reduction in size (Figure 5C). This
result indicates that Medea is required for the increased vein
formation caused by knockdown of dSmad2. The further
reduction of wing size when dSmad2 is depleted in combination
with Medea is also of interest, because it takes place in the almost
complete absence of vein tissue (Figure 5B and 5C). Thus, this
decrease in size cannot be explained by changes in the ratio of
intervein/vein cells, and suggests that dSmad2 also has a growth-
promoting function in the wing, which is independent of its effects
on Mad/Medea signaling.
Mad is epistatic to dSmad2
To further investigate the epistatic relationship between
dSmad2 and Mad in wing development, we compared single
RNAi phenotypes for both genes to the double depletion situation.
The UAS-Mad RNAi construct used targeted the N-terminal
domain (nucleotides 226 to 807) [6]. As described above, dSmad2
RNAi driven in the wing blade formed extra vein tissue around L5
(Figure 6B). RNAi-mediated depletion of Mad resulted in the
complete loss of veins and a strong reduction of the size of the wing
blade (Figure 6C). The exact same phenotype was obtained in the
double dSmad2;Mad RNAi cross, indicating that Mad is epistatic
Figure 4. pMad is expressed in ectopic veins induced within dSmad2 RNAi clones. (A) Pupal wing 25 hrs after puparium formation (APF)
stained with pMad
cter antibody. Nuclear pMad staining is visible in the crossveins and longitudinal veins, most prominently at the distal tips. (B and B’)
dSmad2 RNAi clone marked with GFP induced an ectopic pMad
cter expressing vein (arrowhead) posterior to L5 (arrow). (C–D’) Similar result shown in
an independent experiment. Note the outgrowth of the wing surrounding the ectopic vein (arrowhead in D). (E) dSmad2 clone marked by yellow (y+)
in anterior margin bristles induced the formation of an ectopic vein between the anterior margin and L2. (F) Ectopic vein induced by dSmad2 clone in
the posterior compartment (arrow). (G) dSmad2 clone inducing ectopic vein (arrow in G’) and intervein tissue (arrowhead in G’).
doi:10.1371/journal.pone.0010383.g004
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overgrowth in wing disc tissue caused by Drosophila Smad2 RNAi
using the sd-Gal4 driver (Figure 6E–6H). We conclude that the
effects of dSmad2 depletion on adult wing vein formation and
larval wing disc size require Mad function.
Discussion
We investigated the role of dSmad2 in Drosophila wing
development. Using RNAi lines, which specifically target and
knockdown dSmad2, Mad and Medea, we found a novel role of
dSmad2 in suppressing vein formation in a Mad/Medea-
dependent way. Depletion of dSmad2 generated Mad gain-of-
function phenotypes, and Mad was required for these dSmad2
loss-of-function phenotypes. We conclude that dSmad2 functions
in wing development to inhibit Dpp/Mad signaling.
dSmad2 opposes Mad in wing vein formation
When dSmad2 RNAi was driven throughout the wing blade, it
caused an increase of vein tissue (Figure 1B). This phenotype
resembles elevated Dpp/Mad signaling, which is known to
promote vein differentiation in the wing [45–47]. Misexpression
of activators of the pathway, such as Dpp, constitutively-active Tkv
receptor, and wild-type or stabilized Mad all induce increased vein
tissue to varying degrees [6,35]. The opposite phenotype is seen in
loss-of-function situations of the Dpp/Mad pathway. For example,
both Medea RNAi and Mad RNAi cause loss of vein tissue
(Figures 5B and 6C) [6]. Overexpression of hSMAD3, the
vertebrate Smad most similar to dSmad2, precisely phenocopies
the partial (adult viable) dpp
s6/dpp
hr4 loss-of-function phenotype,
which displays truncations in L4 and L5 (compare Figure 1E to
Figure 4 in [48]). In addition to Dpp/Mad, other signaling
pathways are important in vein development in Drosophila. For
example, EGF/MAPK, Notch and Hedgehog signaling are
important in wing patterning, and disc growth requires Wg
signaling and JAK/STAT activity [38].
We found that low dSmad2 signaling and high Dpp/Mad
signaling result in similar wing vein phenotypes, indicating that
dSmad2 antagonizes Mad in wing tissue determination. The
increase in vein tissue upon dSmad2 knockdown is typically
manifested around L5 in the posterior compartment of the wing
(Figure 3B). Loss of vein tissue in hSMAD3-expressing wings
occurs in the distal parts of L5 and, to a lesser extent, L4. These
site-specific effects on vein formation might be a consequence of
the expression of endogenous Dpp in a stripe along the anterior-
posterior border in the imaginal disc. Dpp phosphorylates Mad,
which forms a gradient that is highest near the source of Dpp, and
low at the lateral areas of the wing disc. The pMad gradient is
steeper in the posterior compartment [42]. Since L5 originates in
the steeper posterior half in an area of low pMad, this region may
be particularly susceptible to changes in cell sensitivity to the Dpp
morphogen gradient.
Clonal analysis supported a role of endogenous dSmad2 in
inhibiting Mad-mediated vein formation. dSmad2 RNAi clones
showed higher levels of nuclear pMad
cter in ectopic vein-like
regions of the pupal wing (Figure 4). Not all cells in the dSmad2
RNAi clones had higher pMad
cter phosphorylation. Veins and
crossveins are induced by the flow of Dpp/Gbb morphogens in the
developing wing field [30,38]. In addition to the formation of
ectopic vein tissue, some dSmad2 RNAi clones on the posterior
margin caused wing outgrowths (Figure 4G). This effect is most
likely due to increased cellular sensitivity to Dpp/Mad signaling,
for it is reminiscent of Dpp clones that act as long-range wing
organizers, inducing wing outgrowths and duplications [31–34].
Mad is required for dSmad2 vein phenotypes
Epistasis experiments were performed using Drosophila lines
expressing single or double RNAi transgenes in order to study the
cross-regulation between dSmad2, Mad and Medea. Mad RNAi
depletion caused complete loss of veins and a strong reduction in
wing size. The exact same phenotype was obtained in the double
Mad;dSmad2 knockdown (Figure 6). Similarly, the effects of
Drosophila Smad2 knockdown on wing disc growth also required
Mad (Figure 6E–6H). This shows that dSmad2 requires Mad in
order to cause its principal phenotypes in wing development.
Wing pattern specification by Mad requires Medea [49]. RNAi-
mediated knockdown of Medea caused a similar phenotype to that
of Mad depletion, but was weaker. This may be due to a partial
loss-of-function effect of the two Medea RNAi constructs tested in
this study, or to Medea-independent functions of Mad. Medea
loss-of-function mutations have been described to cause weaker
phenotypes than Mad mutants [11,43,44]. When dSmad2 and
Medea were depleted simultaneously, we found that Medea was
required for vein induction by dSmad2 RNAi (Figure 5). We
conclude from these epistatic experiments that both Mad and
Figure 5. Medea is required for the effects of dSmad2 on vein
formation. (A and B) Medea RNAi causes marked reduction of veins in
the distal part of the wing. (C) Simultaneous depletion of Medea and
dSmad2 affects vein formation in a similar way as knockdown of Medea
alone. Note that the wing blade is smaller. The remaining wing veins are
numbered.
doi:10.1371/journal.pone.0010383.g005
dSmad2 Opposes Mad Signaling
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dSmad2 knockdown vein phenotypes.
How does dSmad2 oppose Mad?
Figure 7A summarizes our findings on the function of dSmad2
in repressing vein formation in the Drosophila wing. In this diagram,
both, pMad and pdSmad2 require Medea to form a trimeric
complex. In a normal situation, pMad/Medea promotes vein
formation and wing growth, while pdSmad2/Medea heterotrimers
would act as inhibitors that fine-tune venation and growth.
One possible molecular explanation for the inhibitory effect of
dSmad2 on Mad signaling is the competition for Medea, as
depicted in Figure 7B. If Medea were a rate-limiting factor shared
by the Mad and dSmad2 pathways, the knockdown of dSmad2
would free Medea to form complexes predominantly with
pMad
cter, transducing a stronger Mad signal that manifests itself
by extra vein formation. The vertebrate homolog of Medea,
Smad4, has been proposed to act as the rate-limiting step between
Smad1 and Smad2 signal transduction in Xenopus embryos [20].
One reason for the limited availability of Medea may be the
known instability of this protein. Recent work from the Piccolo
group has demonstrated a cycle of monoubiquitination and
deubiquitination of Smad4. Ubiquitinated Smad4 cannot interact
with R-Smads in a trimeric complex, rendering signal transduction
inactive. Subsequent deubiquitination reactivates Smad4 and
makes it accessible for complex formation [50]. This cycle is
essential for TGF-b signaling, since phosphorylated R-Smads are
unable to signal in the absence of the deubiquinase FAM/USP9x
(Fat facets in mouse/Ubiquitin-specific peptidase 9, X-linked). The
Drosophila homolog of FAM, Fat Facets [51], was shown to have
pro-Dpp activity when overexpressed in the Drosophila wing,
suggesting that the regulation of Medea/Smad4 levels is critical
and is conserved between flies and vertebrates.
An additional possibility is that Smad1/Mad and dSmad2
might compete for the type II receptors Punt or Wit which are
common to both pathways. Evidence for ActR2 as the limiting
factor in the switch between TGF-b/Nodal and BMP signaling
has been recently obtained by Yamamoto and co-workers [27]
Figure 6. Mad is epistatic to dSmad2. (A and B) MS1096-Gal4 driving dSmad2 RNAi causes an increase of vein tissue in L5. (C) Depletion of Mad
by RNAi results in small wings lacking veins. (D) Mad;dSmad2 double RNAi wings show identical phenotypes to Mad depletion alone – complete loss
of veins and a small wing blade – showing that Mad is epistatic to dSmad2. (E) Wild type third instar wing imaginal disc. (F) Wing discs become
enlarged when dSmad2 is depleted using RNAi driven by sd-Gal4. (G) Mad depletion reduces wing disc size. (H) Mad is required for the enlargement
of wing discs caused by dSmad2 depletion, compare panels F and H.
doi:10.1371/journal.pone.0010383.g006
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embryo.
An alternative molecular mechanism, depicted in Figure 7C, is
based on the ability of TGF-b receptors to phosphorylate both
Smad2 and Smad1. Mixed Smad1/Smad2/Smad4 trimeric
complexes have been shown in many normal and transformed
cell lines of epithelial and endothelial origin [52–55]. In Drosophila
S2 cells, dActivin and Baboon can induce the phosphorylation of
Mad in addition to that of dSmad2 [17]. Smad1 phosphorylation
by TGF-b receptor requires a combination of Smad1- and
Smad2-specific type I TGF-b receptors in addition to the type II
receptor, a higher ligand concentration, and starts later than that
of Smad2/3 [55].
Several studies have reported different, in some cases, opposing
transcriptional responses to activation of the canonical TGF-b/
Smad2 pathway versus the alternative TGF-b/Smad1/Smad2
signal in normal and cancer cells [53–55]. In the model in
Figure 7C, if dAct/Babo phosphorylated Mad in addition to
dSmad2 in the developing wing, mixed trimeric complexes of
pMad/pdSmad2/Medea might repress vein formation, hence
opposing the vein-promoting function of Dpp/Mad. The ratios
between ‘‘canonical’’ and ‘‘mixed’’ Smad complexes could fine-
tune vein specification in the wing. Other potential mechanisms
could be envisaged as well.
In conclusion, the present study in the Drosophila wing has
revealed that an important function of dSmad2 in wing
development is to antagonize Mad/Dpp signaling during vein
formation. The molecular mechanism of this unexpected inhib-
itory activity of dSmad2 is as yet unknown, and several
hypothetical possibilities have been discussed. Whether signaling
in the opposite direction - an inhibitory effect of Mad on dSmad2
signaling – occurs in Drosophila remains to be investigated. In the
vertebrates, there is much evidence showing that the opposition
between the BMP and TGF-b pathways is mutual




The dSmad2 RNAi strain used in most of this study
(TransformantID14609)wasobtainedfromtheViennaDrosophila
RNAi Center (VDRC). It originates from the ‘‘GD’’ P-element
library of UAS-RNAi constructs cloned into pMF3, a modification
of the pUAST vector [36]. This dSmad2 RNAi is targeted against
nucleotides 652–1049 of the dSmad2 coding sequence, which
corresponds to parts of both the linker region and the MH2 domain
of dSmad2, and was inserted on chromosome 3. A second dSmad2
RNAi strain (Transformant ID 105687, targeted against nucleotides
149–559) from the ‘‘KK’’ phiC31 library, inserted on chromosome
2, was used as a specificity control. Baboon RNAi flies were also
obtained from Vienna (Transformant ID 3825, targeting 171
nucleotides), inserted in chromosome 3. The main Medea RNAi
strain used was: Transformant ID 106767 from the VDRC KK
library, inserted on chromosome 2 and targeted against nucleotides
1434–1883. An independent Medea RNAi line (Transformant ID
19688 from the GD library,inserted on chromosome 3 andtargeted
against nucleotides 258–551) was used as a specificity control and
caused identical phenotypes (data not shown). The Mad RNAi
Figure 7. Hypothetical mechanisms for the opposing effects of
dSmad2 on wing vein formation. (A) The Dpp signal is transduced
by the receptors Thickveins and Punt that activate Mad via C-terminal
phosphorylation. A heterotrimeric complex consisting of pMad and
Medea is formed. This complex is translocated into the nucleus to
initiate target gene expression for vein formation and wing growth. The
Drosophila Activin (dAct) signal is transduced by the receptors Baboon
and Punt; dSmad2 is phosphorylated and associates with Medea
forming a heterotrimer. In the present study, we describe an inhibitory
effect of dSmad2 signaling on vein formation that is mediated by an as
yet unknown molecular mechanism. (B) The competition for Medea
model places Medea as the limiting factor between Mad and dSmad2
signaling pathways. The phosphorylated transcription factors compete
for association with rate-limiting amounts of Medea. Thus, when the
level of dSmad2 is experimentally lowered, the Dpp/Mad branch
receives an excess of Medea with which it can form heterotrimeric
complexes. This leads to an elevated Mad/Medea response, which is
manifested in the formation of extra vein tissue. (C) The mixed pMad/
pdSmad2 complexes model is based on the finding by Gesualdi and
Haerry [17] that the type I receptor Baboon is able to phosphorylate C-
terminal serines of both dSmad2 and Mad. Mixed complexes composed
of pMad, pdSmad2 and Medea may be responsible for inhibiting Mad-
mediated vein formation. In parallel, the canonical pdSmad2/Medea
complex could contribute to wing growth [17] or be involved in other
unknown processes.
doi:10.1371/journal.pone.0010383.g007
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length N-terminal Myc-tagged hSMAD3 (kind gift from Elizabeth
Robertson) was first cloned into the Xenopus expression vector
pCS2+ using BamHI and XhoI restriction sites and then subcloned
into the pUAST vector [56] using NotI and XhoI sites, and stable
transgenic flylines were generated by the Bestgene company (Chino
Hills, CA.).
Fly Strains
Single RNAi strains used were: 1) yw;Bl/CyO;dSmad2 RNAi/
TM6b, 2) yw;Medea RNAi/CyO;TM2/TM6b, 3) yw;Mad
RNAi/CyO;TM2/TM6b. The hSMAD3 wild-type strain used
was yw;hSMAD3/Bl;TM2/TM6b. Mad wild-type was yw;Mad/
CyO;TM2/TM6b [6]. The Strain for the RNAi rescue experi-
ment was: yw;hSMAD3/CyO;dSmad2 RNAi/TM6b. Strains for
epistasis experiments were yw;Mad RNAi/Bl;dSmad2 RNAi/
TM6b, and yw;Medea RNAi/CyO;dSmad2 RNAi/TM6b. Gal4
drivers (Bloomington stock number in parentheses) were as
follows: MS1096-Gal4 (#8696), Scalloped-Gal4 (#8609), and
A9-Gal4. Another strain used in this study was UAS-Dpp (#1486).
Flies were grown at 25uC unless stated differently.
Clonal Analysis
For random ‘‘flp-out’’ clones [39] we crossed females of the
genotype yw;Act.y
+.Gal4;UAS-GFP (kind gift of K. Pappu) to
the following males: ywhsflp;dSmad2 RNAi/dSmad2 RNAi.
Single heat shocks were administered to embryos 24 hrs after
egg laying for 60 min at 37uC. After heat-shock, larvae were
grown at 25uC for recovery and further development.
Wing Disc Preparation
Wing discs were dissected from third instar larvae in cold 0.02%
Triton X-100 PBS (PBST) solution. Discs were fixed in 4%
formaldehyde for 30 minutes on ice, rinsed in PBST, and placed in
DAPI-containing Vectashield (Vector) before mounting on glass
slides.
Pupal Wing Preparation and Immunostaining
In general, paupal wing stainings followed the procedures described
in the supplementary methods of Yan et al. [41]. Briefly, late third
instar larvae were selected and left to develop for 25 hrs after
puparium formation (APF) at 25uC .P u p a ew e r ed i s s e c t e do u to ft h e
puparium case, fixed in 4% formaldehyde in PBS (either overnight at
4uC or 1 hr at room temperature), and rinsed three times in 0.3%
PBST. Pupal wings were dissected from the pupae in PBST, and wing
cuticles manually removed with care. The rest of the protocol was
carried out as described above for wing disc immunostainings, using
0.2% BSA in 0.3% PBST for blocking and antibody dilutions.
Antibodies used were anti-pMad
cter (1:200, generous gift from C.-H.
Heldin), followed by goat anti-rabbit Cy3-conjugated secondary
antibody (1:1000, Jackson Labs). Wing discs and pupal wings were
photographed using a Zeiss Axio Imager.Z1 microscope equipped
with Zeiss ApoTome oscillating grating in the epifluorescence beam,
which significantly reduces out of focus stray light.
Mounting of Adult Wings
Wings were removed from female adult flies and dehydrated in
100% ethanol for 5 mins. The wings were placed on a microscope
slide, and ethanol allowed to evaporate. A small drop of Canada
balsam was dropped onto the wing and a glass coverslip placed on
top. Preparations were flattened at 60uC with a 10 g weight on
top. Wings were photographed with a Zeiss Axiophot microscope
using a Leica DC500 or a Zeiss AxioCam HRc camera. In
general, 10–20 images at different focal planes were integrated
using the AxioVision 4.8 Zeiss software.
Supporting Information
Figure S1 Two non-overlapping dSmad2 RNAi strains cause
extra vein formation and smaller wings. (A) Schematic represen-
tation of the domain structure of dSmad2 indicating the location
of the two VDRC dSmad2 RNAi strains (MH, Mad Homology).
(B) RT-PCR of dSmad2 depleted third instar imaginal wing discs
showing a 70% decrease in mRNA expression compared to
controls. dSmad2 RNAi was driven using scalloped-Gal4; this
experiment shows that dSmad2 is an effective loss-of-function
reagent. (C and D) dSmad2 RNAi KK105687, driven with
MS1096-Gal4 throughout the wing blade, leads to ectopic vein
formation near L5 and smaller wings (compare to Figure 1B). (E
and F) Overlays of dSmad2 RNAi driven wings compared to wild-
type wings. Both dSmad2 RNAi strains reduce the size of the wing
blade. The two independent dSmad2 RNAi strains obtained from
VDRC produce similar phenotypes in the wing: ectopic vein
formation and a moderate decrease in wing size.
Found at: doi:10.1371/journal.pone.0010383.s001 (3.75 MB TIF)
Figure S2 dSmad2 RNAi leads to formation of ectopic bristles
on the wing blade. (A–C) dSmad2 RNAi (GD14609 line)
expressed throughout the wing blade using the A9-Gal4 driver
causes formation of ectopic sensory bristles (arrows) in the anterior
and distal portion of the wing blade at 29uC. (D–F) The
KK105687 dSmad2 RNAi line driven by MS1096-Gal4 leads to
similar ectopic bristle formation when grown at 25uC. In most
cases, a sensory bristle is formed at the end of an extra vein that
branches from the distal part of L2. Sensory bristle formation in
the anterior wing margin requires Wingless (Wg) signaling [57],
and generation of ectopic sensory bristles on the wing blade is seen
in clones of activated Wg, such as Shaggy (Sgg; zeste white 3, zw3;
Glycogen Synthase Kinase 3, GSK3) null clones [58]. In a recent
study on Wg signal integration at the level of Mad, it was shown
that overexpression of Mad mutants with phosphorylation-
resistant GSK3 sites in the linker region of the protein (or ‘‘Mad
GSK3 Mutants’’) resulted in hyperactive forms of Mad that caused
ectopic bristle formation, mimicking activation of Wg signaling.
Conversely, Mad knockdown by RNAi phenocopied Wg loss-of-
functions. It was concluded that the Wg-like phenotypes achieved
by Mad loss- or gain-of-function are mediated through the Wg-
regulated phosphorylation of Mad by GSK3 in the linker region
[6]. Based on these observations, we propose that depletion of
dSmad2 by RNAi causes elevated Mad signaling, comparable to
that attained by Mad GSK3 mutant overexpression. All wings
were from female flies except for E and F. The frequency of the
ectopic bristle phenotype was higher in male flies due to the higher
expression of MS1096-Gal4 in males.
Found at: doi:10.1371/journal.pone.0010383.s002 (3.16 MB TIF)
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